Related Experiment Videos
[Alterations in functional proteins. Calpaine-3 deficiency].
A López de Munain1, A Urtasun, J J Poza
1Servicio de Neurología, Hospital Ntra, Sra. de Aránzazu, San Sebastián, Guipúzcoa.
Revista De Neurologia
|April 2, 1999
Summary
Calpain deficiency causes muscular dystrophy, a genetic disorder affecting muscle structure and function. This condition, characterized by progressive muscle weakness, typically begins in childhood and leads to significant mobility impairment.
Area of Science:
- Neuromuscular disorders
- Enzymatic protein deficiencies
- Genetic basis of muscular dystrophy
Context:
- Calpain deficiency represents the first identified muscular dystrophy linked to mutations in a gene encoding a non-structural enzymatic protein.
- Over 70 mutations identified in the calpain gene on chromosome 15.
- Characterized by a progressive, homogeneous clinical course affecting pelvic and shoulder musculature.
Purpose:
- To analyze the correlation between specific calpain gene mutations and the resulting phenotype.
- To detail the clinical presentation, progression, and diagnostic features of calpain deficiency muscular dystrophy.
- To establish calpain deficiency as a common etiological group within dystrophy syndromes.
Summary:
- Onset typically between ages 8-14, with slow, progressive muscle weakness starting in the pelvis and spreading distally.
- Universal findings include winged scapula and lumbar hyperlordosis; no facial, bulbar, cardiac, or cognitive involvement observed.
- Muscle CT reveals atrophy patterns, primarily in posterior compartments; muscle biopsy is crucial for differential diagnosis.
Impact:
- Provides a comprehensive understanding of calpain deficiency muscular dystrophy, aiding in diagnosis and management.
- Highlights the significance of non-structural enzymatic proteins in muscle health.
- Contributes to the classification and etiological understanding of muscular dystrophy syndromes.